Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells - PubMed (original) (raw)
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
R Manetti et al. J Exp Med. 1993.
Abstract
The effects exerted on the in vitro development of antigen-specific T cell lines and T cell clones by addition or neutralization of interleukin 12 (IL-12) in lymphocyte bulk culture were examined. T cell lines specific for Dermatophagoides pteronyssinus group I (Der p I) derived in the presence of IL-12 exhibited reduced ability to produce IL-4 and increased ability to produce interferon gamma (IFN-gamma), and developed into Der p I-specific CD4+ T cell clones showing a T helper type 0 (Th0)- or Th1-, instead of Th2-, like cytokine profile. In contrast, purified protein derivative (PPD)-specific T cell lines derived in the presence of anti-IL-12 antibody exhibited an increased ability to produce IL-4 and developed into PPD-specific CD4+ T cell clones showing a Th0-, instead of Th1-, like profile. The influence of IL-12 on the cytokine secretion profile of Der p I-specific T cell lines was not prevented by addition to lymphocyte bulk cultures of anti-IFN-gamma antibody, but could be at least partially inhibited by the removal from bulk cultures of CD16+ cells. Thus, IL-12 and CD16+ cells appear to have inhibitory effects on the development of IL-4-producing cells and to play an inductive role in promoting Th1-like responses.
Similar articles
- Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones.
Manetti R, Barak V, Piccinni MP, Sampognaro S, Parronchi P, Maggi E, Dinarello CA, Romagnani S. Manetti R, et al. Res Immunol. 1994 Feb;145(2):93-100. doi: 10.1016/s0923-2494(94)80019-7. Res Immunol. 1994. PMID: 8079050 - Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.
Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S. Maggi E, et al. J Immunol. 1992 Apr 1;148(7):2142-7. J Immunol. 1992. PMID: 1532000 - IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.
Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S. Parronchi P, et al. J Immunol. 1992 Nov 1;149(9):2977-83. J Immunol. 1992. PMID: 1401925 - Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.
Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J. Trinchieri G, et al. Prog Growth Factor Res. 1992;4(4):355-68. doi: 10.1016/0955-2235(92)90016-b. Prog Growth Factor Res. 1992. PMID: 1364096 Review. - Allergen-specific human T cell clones produce interleukin-5 upon stimulation with the Th1 cytokine interleukin-2.
Mori A, Suko M, Tsuruoka N, Kaminuma O, Ohmura T, Nishizaki Y, Ito K, Okudaira H. Mori A, et al. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):220-2. doi: 10.1159/000236983. Int Arch Allergy Immunol. 1995. PMID: 7613136 Review.
Cited by
- γδ T cell-mediated activation of cDC1 orchestrates CD4+ Th1 cell priming in malaria.
Ibraheem Y, Bayarsaikhan G, Macalinao ML, Kimura K, Yui K, Aoshi T, Inoue SI. Ibraheem Y, et al. Front Immunol. 2024 Aug 15;15:1426316. doi: 10.3389/fimmu.2024.1426316. eCollection 2024. Front Immunol. 2024. PMID: 39211036 Free PMC article. - Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop.
Willemsen L, Lee J, Shinde P, Soldevila F, Aoki M, Orfield S, Kojima M, Ricardo DSA, Sette A, Peters B. Willemsen L, et al. bioRxiv [Preprint]. 2024 Aug 7:2024.08.05.606623. doi: 10.1101/2024.08.05.606623. bioRxiv. 2024. PMID: 39149302 Free PMC article. Preprint. - Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study.
Gao Y, Zhou Y, Lin Z, Chen F, Wu H, Peng C, Xie Y. Gao Y, et al. Clin Rheumatol. 2024 Sep;43(9):2843-2856. doi: 10.1007/s10067-024-07059-3. Epub 2024 Jul 13. Clin Rheumatol. 2024. PMID: 38997544 Free PMC article. - Elevated levels of IL-12/IL-23p40 in Nova Scotia Duck Tolling Retrievers with autoimmune disease and lymphoma.
Nilsson M, Kozyrev SV, Saellström S, Johansson S, Andersson G, Lindblad-Toh K, Hansson-Hamlin H, Rönnberg H. Nilsson M, et al. Sci Rep. 2024 May 21;14(1):11624. doi: 10.1038/s41598-024-62265-y. Sci Rep. 2024. PMID: 38773194 Free PMC article. - Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12.
Wang L, Zhou X, Chen X, Liu Y, Huang Y, Cheng Y, Ren P, Zhao J, Zhou GG. Wang L, et al. Mol Ther Oncol. 2024 Apr 6;32(2):200799. doi: 10.1016/j.omton.2024.200799. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38681801 Free PMC article.
References
- J Immunol. 1981 Apr;126(4):1614-9 - PubMed
- J Immunol. 1992 Dec 1;149(11):3495-502 - PubMed
- J Immunol. 1985 Jun;134(6):3662-8 - PubMed
- Nat Immun Cell Growth Regul. 1985;4(3):120-37 - PubMed
- J Clin Invest. 1988 Jan;81(1):200-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous